Search Results - "Ataya, Michelle"

NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake by Alari-Pahissa, Elisenda, Ataya, Michelle, Moraitis, Ilias, Campos-Ruiz, Miriam, Altadill, Mireia, Muntasell, Aura, Moles, Anna, López-Botet, Miguel

“…Epstein Barr virus (EBV) causes a highly prevalent and lifelong infection contributing to the development of some malignancies. In addition to the key role…”
Get full text

Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes by Costa-García, Marcel, Ataya, Michelle, Moraru, Manuela, Vilches, Carlos, López-Botet, Miguel, Muntasell, Aura

“…Natural killer (NK) cells play a dual role in the defense against viral pathogens by directly lysing infected cells as well as by regulating anti-viral T cell…”
Get full text

Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients by Pascual-Guardia, Sergi, Ataya, Michelle, Ramírez-Martínez, Isabel, Yélamos, José, Chalela, Roberto, Bellido, Salomé, López-Botet, Miguel, Gea, Joaquim

“…Chronic obstructive pulmonary disease (COPD) is a chronic and often progressive disorder with a heterogeneous presentation and frequent systemic…”
Get full text

1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact tumor microenvironment by Ataya, Michelle, Currlin, Seth, Rivera, Angie, D’Andrea, Jasmin, Humphrey, Alliyah, Ehrhart, Jared, Chakraborty, Rikhia, Altoik, Soner

“…BackgroundIt has been a significant challenge to select, combine and sequence the multiple FDA-approved IO therapies and pharmaceutical agents, highlighting…”
Get full text

2 Nilogen oncosystems’s 3D-PREDICT tumoroid model is an ex vivo precision oncology and co-clinical trial enrichment platform by Currlin, Seth, Rivera, Angie, Ataya, Michelle, D’Andrea, Jasmin, Humphrey, Alliyah, Ehrhart, Jared, Chakraborty, Rikhia, Altoik, Soner

“…BackgroundImmuno-oncology (IO) therapy with checkpoint inhibitors has demonstrated higher response rate, duration of response, and overall survival than…”
Get full text

Abstract 951: 3D-PREDICT - An ex vivo precision oncology and clinical trial enrichment platform by Nilogen Oncosystems by Ehrhart, Jared, Currlin, Seth, Ataya, Michelle, Humphrey, Alliyah, Chakraborty, Rikhia

“…Abstract Background: Immuno-oncology (IO) therapy with checkpoint inhibitors has demonstrated a higher response rate, duration of response, and overall…”
Get full text

Abstract 6782: 3D-EXpress - an ex vivo platform using viably cryopreserved tumoroids for rapid assessment of targeted therapeutic outcomes by Garrido, Vanessa, Ataya, Michelle, Dhanushkodi, Nisha R., Currlin, Seth, Humphrey, Alliyah, Ehrhart, Jared, Chakraborty, Rikhia

“…Abstract Background: it has been a significant challenge to select, combine, and sequence the multiple FDA-approved IO therapies and pharmaceutical agents,…”
Get full text

Long-Term Evolution of the Adaptive NKG2C+ NK Cell Response to Cytomegalovirus Infection in Kidney Transplantation: An Insight on the Diversity of Host–Pathogen Interaction by Ataya, Michelle, Redondo-Pachón, Dolores, Llinàs-Mallol, Laura, Yélamos, José, Alari-Pahissa, Elisenda, Pérez-Sáez, María J., Altadill, Mireia, Raïch-Regué, Dàlia, Vilches, Carlos, Pascual, Julio, Crespo, Marta, López-Botet, Miguel

“…Abstract Human CMV infection is frequent in kidney transplant recipients (KTR). Pretransplant Ag-specific T cells and adaptive NKG2C+ NK cells associate with…”
Get full text

CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function by Cabo, Mariona, Santana-Hernández, Sara, Costa-Garcia, Marcel, Rea, Anna, Lozano-Rodríguez, Roberto, Ataya, Michelle, Balaguer, Francesc, Juan, Manel, Ochoa, Maria C, Menéndez, Silvia, Comerma, Laura, Rovira, Ana, Berraondo, Pedro, Albanell, Joan, Melero, Ignacio, López-Botet, Miguel, Muntasell, Aura

“…Enhancing natural killer (NK) cell-based cancer immunotherapy by overcoming immunosuppression is an area of intensive research. Here, we have demonstrated that…”
Get more information

Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients by Ataya, Michelle, Redondo‐Pachón, Dolores, Llinàs‐Mallol, Laura, Yélamos, José, Heredia, Gemma, Pérez‐Sáez, María J., Vila, Joan, Costa‐García, Marcel, Raïch‐Regué, Dàlia, Vilches, Carlos, Pascual, Julio, Crespo, Marta, López‐Botet, Miguel

“…Cytomegalovirus (CMV) infection constitutes a complication for kidney transplant recipients (KTR) and CMV‐specific T cells reduce the risk of viral replication…”
Get full text